Detalhe da pesquisa
1.
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic.
J Clin Immunol
; 44(1): 12, 2023 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129351
2.
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy.
J Autoimmun
; 131: 102848, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714496
3.
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health.
Gynecol Endocrinol
; 35(9): 756-761, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30822182
4.
First detection of SARS-CoV-2 lineage A.27 in Sardinia, Italy.
Ann Ist Super Sanita
; 58(1): 1-5, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35324468
5.
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination.
Clin Exp Med
; 22(3): 477-485, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741188
6.
Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid.
Acta Biomed
; 92(3): e2021139, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212928
7.
Evaluation of "Caterina assay": An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification.
Pathogens
; 10(3)2021 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33802049
8.
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study.
Vaccines (Basel)
; 9(12)2021 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34960224
9.
Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study.
Ann Med Surg (Lond)
; 66: 102375, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33968401